Sort
16,300 grants matching “fatty liver disease”
Hepatic lymphocytes and fatty liver disease
$215,250Michael D Wheeler · East Carolina University · R15 · FY2010 · AA
Project 1 - Yan Li, PhD
$215,203Yan Li · University Of Louisville · P20 · FY2022 · GM
Clinical Studies of Inflammatory Bowel Diseases
$215,148Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Small Molecule Screening Against Ethanol Inhibition of Ureagenesis
$214,906John J Lemasters · Medical University Of South Carolina · R21 · FY2014 · AA
Mechanisms of Alcoholic Liver Disease
$214,820Chandrashekhar R Gandhi · University Of Pittsburgh At Pittsburgh · R21 · FY2012 · AA
Acoustic evaluation of micro- and macro-steatosis in transplant livers
$214,545Wayne E Kreider · University Of Washington · R21 · FY2014 · EB
Insulin Resistance In Adolescents With Diabetes: A New Frontier For Cardiovascula
$214,512Kristen J Nadeau · University Of Colorado Denver · R56 · FY2010 · DK
Effect of Organophoshate Exposure on Cholesteryl Ester Hydrolase
$214,500Matthew K Ross · Mississippi State University · R15 · FY2007 · ES
Intestinal failure in children: A contemporary retrospective review by the Pediat
$214,365Robert H Squires · University Of Pittsburgh At Pittsburgh · R21 · FY2009 · DK
Clinical Core
$214,281Andrew P Goldberg · University Of Maryland Baltimore · P30 · FY2007 · DK
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
$214,267Stanley M Stevens · University Of South Florida · R21 · FY2023 · AA
TREATMENT OF LIVER INJURY AND FIBROSIS: SAFETY PHARMACOLOGY AND TOXICOLOGY
$214,260Michael Norman Krupp · Xfibra, Inc. · R44 · FY2019 · DK
A Chronically Implantable Microsensor Array for Monitoring Biomarkers Relevant to
$214,214Florian Solzbacher · University Of Utah · R21 · FY2007 · EB
Human Tissues, Lipidomics, and Proteomics Core
$214,180Jose Orlando Aleman · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2025 · HL
Cholestasis Prevention: Efficacy of IV Fish Oil
$214,028Mark Puder · Boston Children'S Hospital · R01 · FY2008 · FD
Project 4 - Smita Ghare, PhD
$213,947Smita S Ghare · University Of Louisville · P20 · FY2022 · GM
Superfund Chemicals, Nutrition, and Multi-Organ Cardiovascular Risk
$213,807Yekaterina Zaytseva · University Of Kentucky · P42 · FY2024 · ES
IGF::OT::IGF SBIR TOPIC 85 TO SUPPORT THE DEVELOPMENT OF TARGET SPECIFIC MOLECULAR IMAGING AGENTS IN COMBINATION WITH EXISTING IMAGING MODALITIES TO DETECT HIGH RISK ATHEROSCLEROTIC PLAQUE.
$213,776Valerie Humblet · Collagen Medical, Llc · N43 · FY2014 · HL
2/2 Howard-Georgetown Collaborative Partnership in Cancer Research
$213,727Lucile L Adams-Campbell · Georgetown University · P20 · FY2022 · CA
Modulation of Acute Liver Injury
$213,575Mark J. Czaja · Emory University · R01 · FY2015 · DK
Molecular circadian clocks and alcohol-induced liver injury
$213,469Shannon Marie Bailey · University Of Alabama At Birmingham · R21 · FY2018 · AA
Evaluation of MRI & MR Spectroscopic Markers in Non-Alcoholic Fatty Liver Disease
$213,094Aliya Qayyum · University Of California, San Francisco · R01 · FY2011 · DK
Reversal of Tau Pathology with MSUT2 siRNA Conjugates
$213,027Arthur Thomas Suckow · Dtx Pharma, Llc · R41 · FY2020 · AG
Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
$212,929Sanjay Srivastava · University Of Louisville · P42 · FY2020 · ES
Optimizing a human relevant mouse model to study adverse health effects of PFAS
$212,603Jennifer J Schlezinger · Boston University Medical Campus · R21 · FY2024 · ES